Log In
Print
BCIQ
Print
Print this Print this
 

AZD5847

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionOxazolidinone antibacterial inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationTuberculosis
Indication DetailsTreat tuberculosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today